Is There a Cancer Side Effect from GLP-1 Drugs? What California Patients Should Know
GLP-1 receptor agonists—such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and dulaglutide (Trulicity)—have revolutionized treatment for type 2 diabetes and obesity. But as their popularity surges, so do questions about long-term safety. Among the most pressing concerns: Do GLP-1 drugs